Filing Details

Accession Number:
0001209191-21-024234
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-01 18:19:57
Reporting Period:
2021-03-30
Accepted Time:
2021-04-01 18:19:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1807120 Design Therapeutics Inc. DSGN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1728741 Stella Xu C/o Design Therapeutics, Inc.
6005 Hidden Valley Road, Suite 110
Carlsbad CA 92011
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-30 4,439,839 $0.00 4,439,839 No 4 C Indirect See footnote
Common Stock Acquisiton 2021-03-30 280,991 $0.00 4,720,830 No 4 C Indirect See footnote
Common Stock Acquisiton 2021-03-30 10,000 $20.00 4,730,830 No 4 P Indirect By spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See footnote
No 4 C Indirect See footnote
No 4 P Indirect By spouse
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2021-03-30 7,236,938 $0.00 4,439,839 $0.00
Common Stock Series B Preferred Stock Disposition 2021-03-30 458,016 $0.00 280,991 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock has no expiration date.
  2. The general partner of Quan Venture Fund II, L.P. is Quan Venture Partners II, L.L.C. Stella Xu is a managing director of Quan Venture Partners II, L.L.C. and shares the ultimate power to vote or dispose of the shares held by Quan Venture Fund II, L.P. Dr. Xu disclaims beneficial ownership of the shares held by Quan Venture Fund II, L.P., except to the extent of her pecuniary interest.
  3. The shares were purchased in the Issuer's initial public offering.